A randomized, multicenter, open-label phase III trial of hyperthermic intraperitoneal chemotherapy in platinum-resistant recurrent ovarian cancer (KOV-HIPEC-02). This is an ASCO Meeting Abstract from ...
Personalized Chemotherapy on the Basis of Tumor Marker Decline in Poor-Prognosis Germ-Cell Tumors: Updated Analysis of the GETUG-13 Phase III Trial Earlier detection of cancer offers an opportunity to ...
A randomized controlled trial found that MedQuiz, a digital serious game, significantly improved immediate medical terminology acquisition among healthcare undergraduates compared with traditional ...
The traditional gold standard of clinical trials with a randomized, placebo-controlled design involving hundreds of patients ...
Malaria control and elimination is threatened by the spread of insecticide resistance and behavioral adaptation of vectors. Whether mass administration of ivermectin, a broad-spectrum antiparasitic ...
NEW YORK - Oncolytics Biotech Inc. (NASDAQ:ONCY) announced alignment with the U.S. Food and Drug Administration on the design of a pivotal clinical study for pelareorep in patients with unresectable ...
Adjunctive glucocorticoids may reduce mortality among patients with severe community-acquired pneumonia (CAP) in well-resourced settings. Whether these drugs are beneficial in low-resource settings ...
PBFT02 administration resulted in improvements in two disease progression biomarkers, as compared to natural history, reducing brain atrophy and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results